 | • レポートコード：QYR9N7788 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ペプチドベースの代謝障害治療薬のグローバル市場について調査・分析したレポートで、種類別（エクセナチド、リラグルチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ペプチドベースの代謝障害治療薬の世界市場規模 ・主要企業別市場シェア ・ペプチドベースの代謝障害治療薬の世界市場規模：種類別（エクセナチド、リラグルチド、その他） ・ペプチドベースの代謝障害治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・ペプチドベースの代謝障害治療薬のアメリカ市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬のヨーロッパ市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬の中国市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬の日本市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬の東南アジア市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬のインド市場規模（種類別、用途別） ・ペプチドベースの代謝障害治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ペプチドベースの代謝障害治療薬の世界市場予測（2019年-2025年） ・ペプチドベースの代謝障害治療薬の地域別市場予測（2019年-2025年） ... |
A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, efficiency, safety as well as tolerability.North America is expected to dominate the global market in terms of higher market share.
The liraglutide segment by drug class reflects a higher market share by revenue and dominates the global market by drug class.
In 2018, the global Peptide Based Metabolic Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Peptide Based Metabolic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Based Metabolic Disorders Therapeutics development in United States, Europe and China.
The key players covered in this study
AstraZeneca
Ingro Finanz (Bachem)
Eli Lilly
Ipsen
Merck
Novo Nordisk
PolyPeptide Group
Teva Pharmaceutical
Market segment by Type, the product can be split into
Exenatide
Liraglutide
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Peptide Based Metabolic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peptide Based Metabolic Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Peptide Based Metabolic Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide Based Metabolic Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Exenatide
1.4.3 Liraglutide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Peptide Based Metabolic Disorders Therapeutics Market Size
2.2 Peptide Based Metabolic Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Metabolic Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peptide Based Metabolic Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Peptide Based Metabolic Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Peptide Based Metabolic Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide Based Metabolic Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide Based Metabolic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Based Metabolic Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Peptide Based Metabolic Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Peptide Based Metabolic Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
5.2 Peptide Based Metabolic Disorders Therapeutics Key Players in United States
5.3 United States Peptide Based Metabolic Disorders Therapeutics Market Size by Type
5.4 United States Peptide Based Metabolic Disorders Therapeutics Market Size by Application
6 Europe
6.1 Europe Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
6.2 Peptide Based Metabolic Disorders Therapeutics Key Players in Europe
6.3 Europe Peptide Based Metabolic Disorders Therapeutics Market Size by Type
6.4 Europe Peptide Based Metabolic Disorders Therapeutics Market Size by Application
7 China
7.1 China Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
7.2 Peptide Based Metabolic Disorders Therapeutics Key Players in China
7.3 China Peptide Based Metabolic Disorders Therapeutics Market Size by Type
7.4 China Peptide Based Metabolic Disorders Therapeutics Market Size by Application
8 Japan
8.1 Japan Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
8.2 Peptide Based Metabolic Disorders Therapeutics Key Players in Japan
8.3 Japan Peptide Based Metabolic Disorders Therapeutics Market Size by Type
8.4 Japan Peptide Based Metabolic Disorders Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
9.2 Peptide Based Metabolic Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size by Application
10 India
10.1 India Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
10.2 Peptide Based Metabolic Disorders Therapeutics Key Players in India
10.3 India Peptide Based Metabolic Disorders Therapeutics Market Size by Type
10.4 India Peptide Based Metabolic Disorders Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size (2014-2019)
11.2 Peptide Based Metabolic Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size by Type
11.4 Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Ingro Finanz (Bachem)
12.2.1 Ingro Finanz (Bachem) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.2.4 Ingro Finanz (Bachem) Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.2.5 Ingro Finanz (Bachem) Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.3.4 Eli Lilly Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Ipsen
12.4.1 Ipsen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.4.4 Ipsen Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.4.5 Ipsen Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.5.4 Merck Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.6.4 Novo Nordisk Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.6.5 Novo Nordisk Recent Development
12.7 PolyPeptide Group
12.7.1 PolyPeptide Group Company Details
12.7.2 Company Description and Business Overview
12.7.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.7.4 PolyPeptide Group Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.7.5 PolyPeptide Group Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Peptide Based Metabolic Disorders Therapeutics Introduction
12.8.4 Teva Pharmaceutical Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Peptide Based Metabolic Disorders Therapeutics Key Market Segments
Table Key Players Peptide Based Metabolic Disorders Therapeutics Covered
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size Market Share by Type 2014-2025
Figure Exenatide Figures
Table Key Players of Exenatide
Figure Liraglutide Figures
Table Key Players of Liraglutide
Figure Others Figures
Table Key Players of Others
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Peptide Based Metabolic Disorders Therapeutics Report Years Considered
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Peptide Based Metabolic Disorders Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Share by Manufacturers in 2018
Table Global Peptide Based Metabolic Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peptide Based Metabolic Disorders Therapeutics Product/Solution/Service
Table Date of Enter into Peptide Based Metabolic Disorders Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size Share by Type (2014-2019)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size Share by Application (2014-2019)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Peptide Based Metabolic Disorders Therapeutics Revenue Market Share by Application in 2018
Figure United States Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table United States Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table United States Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure Europe Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table Europe Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table Europe Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure China Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table China Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table China Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure Japan Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table Japan Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table Japan Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure India Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table India Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table India Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peptide Based Metabolic Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peptide Based Metabolic Disorders Therapeutics Market Share (2018-2019)
Table Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peptide Based Metabolic Disorders Therapeutics Market Share by Type (2014-2019)
Table Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peptide Based Metabolic Disorders Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Ingro Finanz (Bachem) Company Details
Table Ingro Finanz (Bachem) Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Ingro Finanz (Bachem) Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Ingro Finanz (Bachem) Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Ipsen Company Details
Table Ipsen Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Ipsen Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Ipsen Recent Development
Table Merck Company Details
Table Merck Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Novo Nordisk Recent Development
Table PolyPeptide Group Company Details
Table PolyPeptide Group Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure PolyPeptide Group Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table PolyPeptide Group Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Peptide Based Metabolic Disorders Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size Share by Regions in 2025
Figure United States Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peptide Based Metabolic Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size by Product (2019-2025)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size by Product in 2025
Table Global Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Metabolic Disorders Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測 Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.In 2018, the global Peptide Based Gastrointestinal Disorders Ther…- 世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…
- 世界の代謝性疾患治療薬市場：市場規模・現状・予測 Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.In 2018, the global Metabolic Disorder Therapeutics market size was xx million US$ and it is expected to reach xx mill…
- 世界の核酸ベースの治療薬市場：市場規模・現状・予測 Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…
- 世界の前頭側頭障害の治療市場：市場規模・現状・予測 In 2018, the global Frontotemporal Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Frontotemporal Disorders Treatment status, future forecast, growth opportunity, …